593 research outputs found
Beyond oncological hyperthermia: Physically drivable magnetic nanobubbles as novel multipurpose theranostic carriers in the central nervous system
Magnetic Oxygen-Loaded Nanobubbles (MOLNBs), manufactured by adding Superparamagnetic Iron Oxide Nanoparticles (SPIONs) on the surface of polymeric nanobubbles, are investigated as theranostic carriers for delivering oxygen and chemotherapy to brain tumors. Physicochemical and cyto-toxicological properties and in vitro internalization by human brain microvascular endothelial cells as well as the motion of MOLNBs in a static magnetic field were investigated. MOLNBs are safe oxygen-loaded vectors able to overcome the brain membranes and drivable through the Central Nervous System (CNS) to deliver their cargoes to specific sites of interest. In addition, MOLNBs are monitorable either via Magnetic Resonance Imaging (MRI) or Ultrasound (US) sonography. MOLNBs can find application in targeting brain tumors since they can enhance conventional radiotherapy and deliver chemotherapy being driven by ad hoc tailored magnetic fields under MRI and/or US monitoring
Melaleuca alternifolia Essential Oil: Evaluation of Skin Permeation and Distribution from Topical Formulations with a Solvent-Free Analytical Method
Cyclic nigerosyl-1,6-nigerose-based nanosponges: An innovative pH and time-controlled nanocarrier for improving cancer treatment
Biological Effect Evaluation of Glutathione-Responsive Cyclodextrin-Based Nanosponges: 2D and 3D Studies
A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery
AbstractBackground: Although triiodothyronine deficiency has been described after cardiopulmonary bypass, data supporting its use have been conflicting. A double-blind, randomized, placebo-controlled study was undertaken to further define the effect of triiodothyronine on hemodynamics and outcome after coronary artery bypass grafting. Methods: A total of 170 patients undergoing elective coronary artery bypass grafting were enrolled and completed the study from November 1996 through March 1998. On removal of the aortic crossclamp, patients were randomized to receive either intravenous triiodothyronine (0.4 μg/kg bolus plus 0.1 μg/kg infusion administered over a 6-hour period, n = 81) or placebo (n = 89). Outcome variables included hemodynamic profile and inotropic drug/pressor requirements at several time points (mean ± standard error of the mean), perioperative morbidity (arrhythmia/ischemia/infarction), and mortality. Results: Despite similar baseline characteristics, patients randomized to triiodothyronine had a higher cardiac index and lower inotropic requirements after the operation. Subjects receiving triiodothyronine demonstrated a significantly lower incidence of postoperative myocardial ischemia (4% vs 18%, P = .007) and pacemaker dependence (14% vs 25%, P = .013). Seven patients in the placebo group required postoperative mechanical assistance (intra-aortic balloon pump, n = 4; left ventricular assist device, n = 3), compared with none in the triiodothyronine group (P = .01). There were 2 deaths in the placebo group and no deaths in the triiodothyronine group. Conclusions: Parenteral triiodothyronine given after crossclamp removal during elective coronary artery bypass grafting significantly improved postoperative ventricular function, reduced the need for treatment with inotropic agents and mechanical devices, and decreased the incidence of myocardial ischemia. The incidence of atrial fibrillation was slightly decreased, and the need for postoperative pacemaker support was reduced. (J Thorac Cardiovasc Surg 1999;117:1128-35
Skin Lesion Analyser: An Efficient Seven-Way Multi-Class Skin Cancer Classification Using MobileNet
Skin cancer, a major form of cancer, is a critical public health problem with
123,000 newly diagnosed melanoma cases and between 2 and 3 million non-melanoma
cases worldwide each year. The leading cause of skin cancer is high exposure of
skin cells to UV radiation, which can damage the DNA inside skin cells leading
to uncontrolled growth of skin cells. Skin cancer is primarily diagnosed
visually employing clinical screening, a biopsy, dermoscopic analysis, and
histopathological examination. It has been demonstrated that the dermoscopic
analysis in the hands of inexperienced dermatologists may cause a reduction in
diagnostic accuracy. Early detection and screening of skin cancer have the
potential to reduce mortality and morbidity. Previous studies have shown Deep
Learning ability to perform better than human experts in several visual
recognition tasks. In this paper, we propose an efficient seven-way automated
multi-class skin cancer classification system having performance comparable
with expert dermatologists. We used a pretrained MobileNet model to train over
HAM10000 dataset using transfer learning. The model classifies skin lesion
image with a categorical accuracy of 83.1 percent, top2 accuracy of 91.36
percent and top3 accuracy of 95.34 percent. The weighted average of precision,
recall, and f1-score were found to be 0.89, 0.83, and 0.83 respectively. The
model has been deployed as a web application for public use at
(https://saketchaturvedi.github.io). This fast, expansible method holds the
potential for substantial clinical impact, including broadening the scope of
primary care practice and augmenting clinical decision-making for dermatology
specialists.Comment: This is a pre-copyedited version of a contribution published in
Advances in Intelligent Systems and Computing, Hassanien A., Bhatnagar R.,
Darwish A. (eds) published by Chaturvedi S.S., Gupta K., Prasad P.S. The
definitive authentication version is available online via
https://doi.org/10.1007/978-981-15-3383-9_1
Reliability and inter-observer agreement of dermoscopic diagnosis of melanoma and melanocytic naevi
The aim of this study was to analyse the reliability and the inter- observer agreement of dermoscopy in the diagnosis of melanocytic skin lesions. Nine dermatologists, with a different training experience and who routinely used dermoscopy in different hospitals in Italy, evaluated clinical and dermoscopy photographs of 15 melanocytic lesions (four invasive melanomas, four histologically common naevi, and seven naevi with histological atypia). A further series of dermoscopic photographs of 40 melanocytic lesions was evaluated to quantify inter-observer concordance in recognizing dermoscopic criteria. Compared to the true (histological) diagnosis, clinical diagnosis (categories: melanoma, common naevus, atypical naevus) was correct in 40% of cases (range, 27-53%). The percentage raised to 55% (40-73%) by the use of dermoscopy, with an average improvement of 15.6%. Concerning melanoma, clinical diagnosis resulted in a sensitivity of 41.9%, specificity of 77.8%, positive predictive value (PPV) of 36.1%, negative predictive value (NPV) of 81.8%. By using dermoscopy, an improvement of diagnostic performance was found (sensitivity 75%, specificity 88.8%, VPP 71.0%, VPN 90.7%). The inter-observer agreement in melanoma diagnosis, by using dermoscopy, was similar to that obtained by clinical examination (k statistics = 0.54 and 0.52, respectively). Concerning dermoscopic criteria, the best agreement among observers was found for pseudopods, a dermoscopic parameter related to the radial growth phase of melanoma. We conclude that dermoscopy is an useful tool for a non-invasive diagnosis of melanocytic skin lesions, improving the diagnostic performance compared to clinical examination
Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region.
Summary The family of the poly(adenosine diphosphate-ribose) polymerase (PARP) proteins is directly
involved in genomic stability, DNA repair, and apoptosis by DNA damage. In this study, we evaluated
the role of PARP-1 in melanoma and its prognostic importance. We studied by immunohistochemistry
and Western blot analysis PARP-1 expression in a selected series of 80 primary melanoma of the head
and neck region. The results were correlated with tumor thickness and patient’s outcome. A follow-up
of at least 3 years was available. Fifteen cases of benign melanocytic nevi were used as controls.
Normal melanocytes showed only scattered, focal nuclear positivity and were considered as negative
for PARP-1 expression by immunohistochemistry (score, 0). Thirty cases of melanoma (37.5%)
showed nuclear expression of PARP-1 in both radial and vertical growth phases. Western blot analysis
showed the presence of a high signal for full-length PARP-1 only in the cases with high
immunohistochemical (nuclear) expression of protein (score, ++/+++) in both radial and vertical
growth phase. A significant correlation was present between PARP-1 expression in vertical growth
phase and the thickness of tumor lesion ( P = .014); all but one tumor measuring less than 0.75 mm showed no or low PARP-1 expression. No correlation was found between PARP-1 expression in radial
growth phase and tumor thickness ( P = .38, data not shown). These data suggest that PARP-1
overexpression is a potential novel molecular marker of aggressive cutaneous malignant melanoma and
a direct correlation between PARP-1–mediated inhibition of the apoptosis and biologic behavior of
cutaneous malignant melanoma
- …